Elamipretide (SS-31)
Cardiovascular
Targets the inner mitochondrial membrane by binding cardiolipin, restoring mitochondrial function.
Community
0
Tracking
0
Doses Logged
4mg/day SubQ
Common Dose
—
Adverse Rate
All dosages:4mg/day SubQ40mg IV (clinical)
Reported Adverse Effects
No adverse effects reported yet
Community Consensus
No consensus claims yet — be the first to contribute
Literature
No studies linked yet — know of one? Share it in the discussion
Discussion
No discussion yet — be the first to share your experience